Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Eye, Ear & Vision

Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro

PBM ameliorated lesions of diabetic retinopathy in vivo and reduced oxidative stress and cell death in vitro. PBM has been documented to have minimal risk.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

In rat and cultured retinal cell models of diabetes, the authors report that daily 670-nm light treatment was associated with less retinal ganglion cell death, better electroretinogram responses, reduced oxidative stress and reduced inflammation. The authors describe these as early, preclinical findings in animals and cells, not human results.

Who or what was studied
Streptozotocin-induced diabetic rats and cultured retinal cells
Wavelengths
670 nm
Limits stated in the abstract
The study used animal and cultured cell models, so the findings may not apply to humans.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on iovs.arvojournals.org.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Oxidative stress, Retina, Near-infrared, Inflammation, Biomarker. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies